The effect of thyrotropin-releasing hormone (TRH) was studied on local CBF (LCBF) in normal con scious rats. LCBF was measured by the auto radiographic [14C]iodoantipyrine method 5 min after TRH (5 mg/kg, i.v.) administration. TRH significantly in creased LCBF in 22 of 33 brain regions. This increase of LCBF exceeded 100% of the control values in the cere bral cortices, whereas there was no significant increase in
The hypothalamic tripeptide, a thyrotropin-re leasing hormone (TRH), is widely distributed throughout the central nervous system (CNS) out side the hypothalamus (Jackson and Reichlin, 1974; Oliver et aI., 1974; Winokur and Utiger, 1974; Brownstein et aI., 1975; Kubek et aI., 1977; Lep paluoto et aI., 1978) . Receptors for TRH have been identified in the CNS of several species (Burt and Snyder, 1975; Taylor and Burt, 1982; Manaker et aI., 1986) . It is well recognized that TRH, when administered exogenously, exerts multiple effects on the integrative functions of the CNS (Nemeroff et aI., 1979; Morley, 1979; Yarbrough, 1979) . These are independent of its endocrine effects (Nemeroff et aI., 1979; Morley, 1979; Yarbrough, 1979) . TRH is known to have arousing, analeptic, and hyper thermic excitatory effects on the CNS, as well to stimulate of the spontaneous motor activity of ani mals. In addition, TRH is known to antagonize the depressant effects of barbiturates and ethanol and white matter or in some gray matter structures. The in crease of CBF following TRH administration was abol ished by pretreatment with indomethacin (5 mg/kg, i.v.) . The mechanisms underlying the increase of CBF follow ing TRH administration are discussed in relation to pros taglandin metabolism. Key Words: Autoradiography Cerebral blood flow-Prostaglandin synthesis inhibitor thyrotropin-releasing hormone.
other general anesthetics in mice and rabbits (Kruse, 1974; Prange et aI., 1974; Breese et aI., 1974 Breese et aI., , 1975 Cott et aI., 1976; Horita et aI., 1976) . In recent reports (Koskinen and Bill, 1984; Koskinen and Sperber, 1986; Koskinen, 1986a,b) , TRH pro duced an increase of cerebral blood flow (CBF) in anesthetized rabbits and rats, but this increase of CBF is not explained by either a change in mean arterial blood pressure (MABP) or an increase in metabolic demand. Contrary to its excitatory be havioral effects on the CNS, it was shown that TRH suppressed cerebral glucose utilization in the con scious rat (Nagai et aI., 1980a) . On the other hand, Nagai et aI. (1980a) have shown that TRH reversed suppressed cerebral glucose metabolism in pento barbitalized rats. Thus, the effect of TRH on CBF and cerebral metabolism may differ between the conscious and anesthetized states. However, little is known about how TRH affects local CBF (LCBF) in the conscious state. Therefore, utilizing the au toradiographic 14C-iodoantipyrine method (Saku rada et aI., 1978) , the present study endeavored to measure the effect of TRH on the LCBF in the con scious rat.
TRH has other actions. For example, TRH pro motes the breakdown of phosphatidylinositol (Sut ton and Martin, 1982; Martin, 1983) and calcium ion mobilization (Drummond, 1985) in clonal GH3 rat pituitary cells. Arachidonic acid is reportedly re leased by phospholipid degradation, including that of phosphatidylinositol (Hirata and Axelrod, 1980; Lapetina et aI., 1981; Nishizuka, 1984a,b) . In addi tion, prostaglandins are thought to play important roles in cerebral circulation in physiological and pathological states (Pickard, 1981; Siesjo and N ils son, 1982) . Hence, the second purpose of this study is to clarify how prostaglandin systems might par ticipate in the change of CBF following TRH ad ministration. The effects of TRH on LCBF were compared with, or without, indomethacin, a pros taglandin synthesis inhibitor.
MATERIALS AND METHODS

Animals
All experiments were performed on male Sprague Dawley rats of S.P.F. strain (Charles River Japan, Inc.) weighing 280-470 g. The animals were allowed to have free access to food and tap water until the experiment.
Materials
4-Iodo-[N-methyl-J4C]antipyrine ([ J4C]IAP, specific activity SI mCi/mmol) was purchased from Amersham Japan Ltd. Other drugs used were TRH (L-PYro glutamyl-L-histidyl-L-proline amide L-tartrate monohy drate; Takeda, Osaka, Japan) and indomethacin (Wako, Osaka, Japan). TRH was dissolved in 0.9% physiological saline (saline), and indomethacin was solubilized in 0.1 N sodium phosphate buffer (pH 8.0) just prior to adminis tration. These drugs were injected in a volume of 0.1 mlllOO g body weight. The dose of TRH is expressed in terms of the weight of the salt.
CBF measurement
LCBF was measured by the method described by Sakurada et al. (1978) . The animals were anesthetized with halothane and N20, and polyethylene catheters were inserted into both right and left femoral arteries and veins. The rats were then immobilized in loose-fitting plaster casts and were allowed to recover from anesthesia for at least 2 h. After recovery, HID-ISO fLCilkg body weight of [J4C]lAP in 1.0 ml of saline was continuously infused via the left femoral vein for a period of I min at a constant infusion rate. During the infusion period, IS-20 timed arterial blood samples of -60 fLl (2 drops) were collected through the right arterial catheter into tared scintillation vials. After a I-min infusion, the animals were killed by the injection of 1 ml of saturated KCl so lution via the right venous catheter. The brain was then removed immediately and frozen in isopentane chilled to -40--SO°C. The brains were coated with chilled embed ding medium (Ames O.C.T. compound; Ames Company, Elkhart, IN, U.S.A.), stored at -80°C (for less than a week), and cut into 20-fLm sections at -20°C in a cryostat (Bright Cryostat model OTF/AS; Bright Instrument Co. Ltd., Huntingdon, England). The sections were then dried and placed in the x-ray cassette along with cali brated [14C]micro-scale standards (Amersham Japan, To kyo, Japan). Autoradiograms were generated by apposing the sections against Kodak medical x-ray film (type NMC-I ®) for 7 days. The films were then developed and fixed by automatic film processor (Fuji RK x-ray film processor, Fuji Medical System, Tokyo, Japan). Local tissue 14C concentrations were determined from the au toradiograms by densitometric analysis using a densitom eter (Drum scan densitometer model 260S; Abe Sekkei, Tokyo, Japan) with an aperture of 0.1-0.2 mm. Blood [14C]IAP concentration was measured by liquid scintilla tion counting using a Beckman LS 9800 liquid scintillation counter (Beckman Instruments Inc., Fullerton, CA, U.S.A.). The blood samples were weighed and solubi lized by adding 0.5 ml of a quaternary ammonium base (Protosol®; New England Nuclear Corp., Boston, MA, U.S.A.) to each vial and then incubating for 10 min at room temperature. After incubation, 0.2S ml of saturated H202 solution, 4 ml of scintillation fluid (ACS-II; Amer sham), and O.S ml of O.S N HCI solution was added to each vial. After the samples had been left overnight (about 18 h) at room temperature, the activity was counted. Quenching correction was accomplished by means of external standardization. Concentration of the tracers per unit weight of blood and tissue was deter mined from the amount of measured radioactivity and the weight of samples. LCBF was calculated from the local concentrations of tissue 14C and the time course of the blood e4C]IAP concentrations.
The animals were killed by the injection ofKCl solution (i. v.) instead of the standard decapitation. This KCl method might cause errors in the timing of death. How ever, our control CBF values after KCI injection corre lated well (y = 0.98x + 2.6, r = 0.96, p < 0.01) with the data reported by Sakurada et al. (1978) . Thus, the influ ence on the CBF values of the errors in the timing of death were considered to be minor.
LCBF was measured S min after TRH (S mg/kg, i.v.) administration in a group of 6 animals (TRH group). With the same procedure, S animals given saline injection in place of TRH served as controls (control group). In an other group of S rats, indomethacin (S mg/kg, i.v.) was injected 30 min prior to TRH administration (indometha cin pretreatment group). LCBF was also measured in S animals given indomethacin and saline (indomethacin alone group).
Arterial blood pressure was continuously monitored via the left arterial catheter by means of a pressure trans ducer and Minipolygraph (Nihon Kohden, Tokyo, Japan). Immediately prior to TRH or saline injection, ar terial blood was analyzed for hematocrit and pH, Paco2 and Pao2 using a pHlblood gas analyzer system 1303 (In strumentation Laboratory Inc., Lexington, KY, U.S.A.). As the physiological parameters were not measured after TRH administration in the animals in which LCBF was measured, these parameters, except for blood pressure, were measured before and S min after TRH administra tion in 7 animals on a separate occasion.
Analysis of data
All data are expressed as the means ± SD. Statistical analysis was performed using the two-way analysis of variance (ANOV A) to verify the significant differences among the animal groups. Conditions compared in the ANOVA were drug effect (saline or TRH) versus state of indomethacin pretreatment (with or without pretreat ment). Tukey's test was applied to the specific compari sons between treatment means for the regions in which significant effects were seen by the two-way ANOV A.
Student's paired t test was used to determine probability when comparing physiological parameters before and af ter TRH administration. The difference was considered to be statistically significant when p was less than 0.05.
RESULTS
TRH caused a significant increase in LCBF (p < 0.05 by two-way ANOV A) in 22 of 33 brain regions (Table O. There was also a significant interaction between the effect of TRH and indomethacin pre treatment in 23 of 33 brain regions by two-way ANOV A. According to Tukey's test, a significant increase of CBF was seen in those 22 regions of the brain in the TRH group as compared with the con trol group. The increase of LCBF exceeded 100% of the control values in the parietal, sensory-motor, olfactory, and frontal cortices. The increase was between 52 and 92% in the visual and auditory cor tices, thalamus, mammillary body, caudate nu cleus, vestibular nucleus, cochlear nucleus, lateral lemniscus, and cerebellar nuclei. A significant in crease in LCBF was also observed in the medial and lateral geniculate bodies, hypothalamus, hip pocampus (ammon's horn), amygdala, nucleus ac cumbens, superior olivary nucleus, and superior colliculus. LCBF showed no significant change in the hippocampus (dentate gyrus), septal nucleus, globus pallidus, substantia nigra, inferior colliculus, pontine gray matter, cerebellar cortex, corpus cal losum, internal capsule, or cerebellar white matter.
Although LCBF values were slightly lower in the indomethacin-alone group than in the control group, a significant reduction was noted only in the nucleus accumbens (p < 0.05) by Tukey's test (Fig.  la) . No significant difference was seen in the LCBF between the indomethacin pretreatment group and the group receiving indomethacin alone by Tukey's test (Fig. Ib) .
As shown in Table 2 , physiological parameters, including the hematocrit, P2C02, Pao2, and MABP, measured before TRH did not differ significantly among the four groups. Thus, indomethacin had no influence on the blood gases or blood pressure. Al though a statistically significant effect (p < 0.05) of indomethacin on pH was seen by two-way ANOV A, it was not large enough to be statistically significant by Tukey's test. The MABPs before and 5 min after TRH injection were 130 ± 9 and 138 ± 14 mm Hg (mean ± SD), respectively. There were temporary changes in the MABP after TRH injec tion, but the MABP returned to the baseline level before the CBF measurement in all but one case with indomethacin pretreatment in which the in crease of MABP had been observed even during the CBF measurement. The average MABP at maxi- indomethacin pretreatment (indomethacin + TRH) groups. All values designate the mean from five animals. Local CBF showed no significant difference between the two groups. Data are means ± SD from five or six (TRH group) animals. a Statistically significant effect of indomethacin pretreatment at p < 0.05 as determined by two-way ANOV A. There was no significant difference in pH between the control group and the indomethacin-alone or indomethacin pretreatment groups as determined by Tukey's test.
mum change was 141 ± 23 mm Hg (mean ± SD), and the maximum change in MABP was observed at 0.8 ± 0.5 min (mean ± SD) after TRH administra tion. Table 3 shows a comparison of the blood gases and pH before and 5 min after TRH. Paco2 and Pao2 did not differ significantly before and after TRH administration (Student's paired t test). A slight but significant (p < 0.01) decrease of pH was observed 5 min after TRH by the Student's paired t test.
DISCUSSION
The present study shows that TRH markedly in creased the CBF of normal conscious rats in 22 of 33 brain regions, including cerebral cortices. This increase of CBF was blocked by pretreatment with indomethacin.
TRH has been reported to evoke a large array of behavioral and vegetative symptoms in rats in a dose range of 0.1-100 mg/kg, i. p. (Kruse, 1974 (Kruse, , 1977 Goujet et aI., 1975) . These include hypermo tility, excitation, tachypnea, hyperthermia, rearing, grooming, tail-rattling, tail-elevation, tremor, body shakes, etc. (Kruse, 1974 (Kruse, , 1977 Goujet et aI., 1975) . Schenkel-Hulliger et ai. (1974) showed that the in travenous injection of relatively small doses of TRH (0.3-3 mg/kg) caused muscle tremor, excitation, tail-lifting, and pilo-erection. The dose of TRH tar trate (5 mg/kg, i. v.) used in our study corresponds with the dose of 3.42 mg/kg, as the TRH molecule per se. Based on these cited laboratory data con cerning the excitatory effects of TRH, it can be ex pected that TRH will increase CBF as long as the coupling of blood flow to brain function is main tained. In anesthetized animals, it was suggested that TRH increased CBF (Koskinen and Bill, 1984; Koskinen, 1986a,b) . In the present study carried out in normal conscious rats, TRH also increased LCBF in the majority of brain regions. In the pre vious literature, TRH was thought to counteract the depressant effect of anesthetics (Kruse, 1974; Prange et aI., 1974; Breese et aI., 1974 Breese et aI., , 1975 Cott et aI. , 1976; Horita et aI., 1976) . As far as cerebral glucose metabolism is concerned, the effect of TRH seemed to differ between the conscious and pento barbitalized states (Nagai et aI., 1980a) . The present results, however, confirm that TRH can increase CBF in either the conscious or the anesthetized state.
The excitatory effects of TRH are thought to oc cur shortly after it is administered. Nagai et ai. (1980b) showed that the brain concentration of TRH reached its peak 1-2 min after intravenous injec tion. They used the same dose of TRH as used in this study and reported a half-life of TRH as 3.1 min in the brain. Elevation of the blood TSH level after TRH injection reportedly occurs much more slowly than that of TRH itself (Macho and Strbak, 1979) . In the present study, CBF was measured 5 min after TRH given intravenously. As the blood TSH level rises relatively late after TRH injection, TSH may have rather little effect on the CBF level measured shortly after injection.
TRH has a pressor effect in various species. TRH caused a significant increase of MABP in anesthe tized rabbits (Koskinen and Bill, 1984; Koskinen, 1986b) , rats (Koskinen, 1986a) , and curarized rab bits (Beale et aI., 1977) . On the contrary, Nagai et ai. (1980a) reported that no significant change in MABP occurred in conscious rats after TRH (5 mg/ kg, i.v.) . In our study, the changes of MABP after TRH administration were only temporary in all but one case with indomethacin pretreatment. These changes of MABP after TRH injection (from 130 to 141 mm Hg as a mean value) were still in the range of autoregulation. Thus, the increase of CBF fol lowing TRH administration is not primarily associ ated with changes in MABP.
TRH stimulates respiration in mice and rats (Kruse, 1974; Schenkel-Hulliger et aI., 1974) . In the present study, however, TRH caused no significant change in Paco2 or Pao2, although a slight, signifi cant decrease in pH was seen. As blood gases were not altered after TRH administration, this reduction in pH may reflect the dissociation of tartaric acid from its complex with TRH. The intravascular in jection of a low pH solution does not result in CBF changes if P aco2 is maintained constantly and if the blood-brain barrier remains intact (Lassen, 1959; Harper and Bell, 1963) . Thus, this slight decrease in pH is not considered to be responsible for the in crease of CBF after TRH administration.
TRH is known to have analeptic effects, and it also activates the electroencephalogram (EEG) (Prange et aI., 1974; Breese et aI., 1975; Beale et aI., 1977) . Therefore, the increase of CBF could be ex plained by the activation of cerebral metabolism at a time when the coupling of blood flow to metabo lism was being maintained. The previous literature (Nagai et aI., 1980a) showed that TRH suppressed cerebral glucose metabolism in conscious rats, al though TRH produced a significant increase in glu cose utilization in pentobarbitalized rats. However, the fall of the arteriovenous difference in oxygen saturation after TRH administration was not signif icant in anesthetized rabbits (Koskinen and Bill, 1984) . In clinical trials of patients with spinocere bellar degeneration using positron emission tomog raphy, a significant increase of CMR02 was seen during chronic intravenous therapy with TRH in pa tients whose baseline cortical CMR02 values were lower than normative values. In contrast, CMR02 values even decreased with therapy in those whose baseline CMR02 was relatively preserved (Nagata et aI., 1988) . Therefore, these experimental and clinical data could support the interpretation that the increase in CBF is primarily associated with TRH. Yarbrough (1979) suggested that TRH stimulated various components of the reticular activating sys tem and cholinergic neurons. Acetylcholine (ACh) releasing pathways are intimately associated with the reticular activating system. Iadecola et al. (1981) , on the other hand, demonstrated that elec trical stimulation of the dorsal medullary reticular formation globally increased CBF in rats. In addi tion, ACh is known to dilate cerebral arteries and to increase CBF in various species (Edvinsson and MacKenzie, 1977) . Thus, TRH is considered to ex ert at least some of its effects on CBF through cholinergic mechanisms. However, Furchgott and Zawadzki (1980) have shown that indomethacin had no effect on the relaxing action of ACh using the isolated rabbit's aorta and other arteries. Therefore, an ACh-mediated mechanism appears to be ruled out because indomethacin blocked the increase of CBF induced by TRH.
The increase of CBF by TRH is considered to be associated with the prostaglandin systems, which may cause cerebral vasodilation. Indomethacin in hibits not only fatty acid cyclooxygenase, but also phospholipase A2 (Kaplan et aI., 1978) , cyclic AMP dependent protein kinase (Kantor and Hampton, 1978) , and other enzymes (Flower, 1974) . Siegel et al. (1979) reported that indomethacin also inhibits peroxidase activity in the lipoxygenase pathway. These results may make the interpretation more complicated. Goueli and Ahmed (1980) , however, suggested that the inhibition of protein kinase oc curs only at a concentration of indomethacin of 10-4 M or above. Hucker et al. (1966) reported that the plasma concentration 15 min after indomethacin administration (10 mg/kg, i.v.) was 60.2 J..L g/ml, dur ing which about 90% of the compound was bound to the nondiffusible constituents of the plasma, and the brain tissue/plasma ratio was 0.02. Accordingly, the plasma level will presumably reach as high as 30.1 J..L g/ml when a dose of indomethacin half of that (5 mg/kg) is given intravenously. Accordingly, the free plasma and brain concentration of indometha cin in this present study will presumably be on the orders of 8 x 10-6 M and 2 x 10-6 M, respectively. This plasma and brain concentration of indometha cin is much lower than the level that inhibits the protein kinase. Thus, it is plausible that TRH may exert its effect through the arachidonic acid metab olite(s). The same dose of indomethacin as used in our study inhibits 80% of the prostaglandin synthe sis in the brain and blood vessels of rats (Abdel Halim et aI., 1978) . This may explain the fact that no significant interaction was observed between TRH and indomethacin pretreatment in some brain regions. Koskinen (1986b) suggested that TRH activates an intrinsic cerebral vasodilating pathway (in the submesencephalic brainstem, including the fastigial nucleus), which results in an increase of CBF. Na kai et al. (1982) demonstrated that electrical stimu lation of the fastigial nucleus markedly increased CBF resulting from the global primary cerebral va-sodilation. However, the pattern of CBF increase by electrical stimulation is quite different from that observed in our experiments. Moreover, the pattern of CBF increase shown in our data did not corre spond either to the distribution of endogenous TRH (Oliver et aI., 1974; Winokur and Utiger, 1974) or to TRH receptor densities (Burt and Snyder, 1975; Taylor and Burt, 1982) in the rat's brain. Thus, TRH is considered to increase CBF via a direct effect on cerebral vessels in addition to activation of the intrinsic cerebral vasodilating pathway. On the other hand, Hanko et ai. (1982) reported that cere bral vessels of cats in vitro did not respond to TRH. Therefore, it might be speculated that the intrinsic neuronal pathway, which may be activated by TRH, stimulates the arachidonic acid metabolism in the endothelium of cerebral vessels.
Our studies emphasize that TRH increases CBF by a vasodilating mechanism in the vessel wall, one mediated by arachidonic acid metabolite(s), and is therefore inhibited by indomethacin.
